1. Home
  2. DUOT vs FATE Comparison

DUOT vs FATE Comparison

Compare DUOT & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOT
  • FATE
  • Stock Information
  • Founded
  • DUOT 1990
  • FATE 2007
  • Country
  • DUOT United States
  • FATE United States
  • Employees
  • DUOT N/A
  • FATE N/A
  • Industry
  • DUOT Computer Software: Prepackaged Software
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DUOT Technology
  • FATE Health Care
  • Exchange
  • DUOT Nasdaq
  • FATE Nasdaq
  • Market Cap
  • DUOT 125.8M
  • FATE 116.5M
  • IPO Year
  • DUOT N/A
  • FATE 2013
  • Fundamental
  • Price
  • DUOT $7.93
  • FATE $1.41
  • Analyst Decision
  • DUOT Strong Buy
  • FATE Hold
  • Analyst Count
  • DUOT 2
  • FATE 6
  • Target Price
  • DUOT $12.75
  • FATE $3.30
  • AVG Volume (30 Days)
  • DUOT 265.4K
  • FATE 2.4M
  • Earning Date
  • DUOT 11-18-2025
  • FATE 11-11-2025
  • Dividend Yield
  • DUOT N/A
  • FATE N/A
  • EPS Growth
  • DUOT N/A
  • FATE N/A
  • EPS
  • DUOT N/A
  • FATE N/A
  • Revenue
  • DUOT $15,387,935.00
  • FATE $8,470,000.00
  • Revenue This Year
  • DUOT $294.36
  • FATE N/A
  • Revenue Next Year
  • DUOT $43.87
  • FATE N/A
  • P/E Ratio
  • DUOT N/A
  • FATE N/A
  • Revenue Growth
  • DUOT 172.93
  • FATE N/A
  • 52 Week Low
  • DUOT $3.05
  • FATE $0.66
  • 52 Week High
  • DUOT $9.27
  • FATE $3.50
  • Technical
  • Relative Strength Index (RSI)
  • DUOT 60.58
  • FATE 72.98
  • Support Level
  • DUOT $7.18
  • FATE $0.95
  • Resistance Level
  • DUOT $7.83
  • FATE $1.37
  • Average True Range (ATR)
  • DUOT 0.45
  • FATE 0.10
  • MACD
  • DUOT 0.01
  • FATE 0.04
  • Stochastic Oscillator
  • DUOT 60.70
  • FATE 90.38

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: